Symptomatic and Palliative Care for Stroke Survivors Authors
First Online: 19 January 2012 Received: 11 July 2011 Revised: 13 October 2011 Accepted: 30 November 2011 DOI:
Cite this article as: Creutzfeldt, C.J., Holloway, R.G. & Walker, M. J GEN INTERN MED (2012) 27: 853. doi:10.1007/s11606-011-1966-4 Abstract
Stroke is the leading cause of disability and one of the most common causes of death worldwide. Outside the setting of acute management, secondary prevention and stroke rehabilitation, little has been written to address the ongoing symptomatic and palliative needs of these patients and their families. In this literature review, we look beyond secondary prevention with the aim of providing evidence-informed management guidelines for the myriad and often under-recognized symptomatic and palliative care needs of stroke survivors. Some of the most common and disabling post-stroke symptoms that are reviewed here include central post-stroke pain, hemiplegic shoulder pain, painful spasticity, fatigue, incontinence, post-stroke seizures, sexual dysfunction, sleep-disordered breathing, depression and emotionalism. We review the role of caregivers and explore ways to support them and, lastly, remind the reader to be perceptive to the patient’s spiritual needs. The literature is most robust, including controlled trials, for central post-stroke pain and depression. Synthesis and discussion outside these areas are frequently limited to smaller studies, case reports and expert opinion. While some data exists to guide informed decision-making, there is an urgent need to document best practice and identify appropriate clinical standards for the full spectrum of symptoms experienced by stroke survivors. We present the current and established data to aid health care providers in symptomatic and palliative management of stroke survivors.
KEY WORDS stroke palliative care symptom management
An erratum to this article is available at
. http://dx.doi.org/10.1007/s11606-014-2876-z References
AHA/ASA. Heart Disease and Stroke Statistics – 2010 Update; 2010.
Adams HP Jr, del Zoppo G, Alberts MJ, et al.
Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655–1711.
Morgenstern LB, Hemphill JC 3rd, Anderson C, et al.
Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–2129.
Langhorne P, Coupar F, Pollock A.
Motor recovery after stroke: a systematic review. Lancet Neurol. 2009;8:741–754.
Langhorne P, Bernhardt J, Kwakkel G.
Stroke rehabilitation. Lancet. 2011;377:1693–1702.
Duncan PW, Zorowitz R, Bates B, et al.
Management of Adult Stroke Rehabilitation Care: a clinical practice guideline. Stroke. 2005;36:e100–e143.
Stevens T, Payne SA, Burton C, Addington-Hall J, Jones A.
Palliative care in stroke: a critical review of the literature. Palliat Med. 2007;21:323–331.
Edlund WGG, So Y, Franklin G. Clinical Practice Guideline Process Manual. online; 2004.
Kehayia E, Korner-Bitensky N, Singer F, et al.
Differences in pain medication use in stroke patients with aphasia and without aphasia. Stroke. 1997;28:1867–1870.
Jönsson AC, Lindgren I, Hallström B, Norrving B, Lindgren A.
Prevalence and intensity of pain after stroke: a population based study focusing on patients’ perspectives. J Neurol Neurosurg Psychiatry. 2006;77:590–595.
Klit H, Finnerup NB, Jensen TS.
Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009;8:857–868.
Leijon G, Boivie J.
Central post-stroke pain—a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36:27–36.
Saarto T, Wiffen PJ.
Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;4:CD005454.
Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen TS.
Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology. 2001;56:184–190.
Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R.
Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011;152:1018–1023.
Serpell MG, Neuropathic pain study group.
Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain. 2002;99:557–566.
Frese A, Husstedt IW, Ringelstein EB, Evers S.
Pharmacologic treatment of central post-stroke pain. Clin J Pain. 2006;22:252–260.
Lindgren I, Jonsson AC, Norrving B, Lindgren A.
Shoulder pain after stroke: a prospective population-based study. Stroke. 2007;38:343–348.
Van Peppen RP, Kwakkel G, Wood-Dauphinee S, Hendriks HJ, Van der Wees PJ, Dekker J.
The impact of physical therapy on functional outcomes after stroke: what’s the evidence? Clin Rehabil. 2004;18:833–862.
Singh JA, Fitzgerald PM.
Botulinum toxin for shoulder pain. Cochrane Database Syst Rev. 2010;9:CD008271.
Koog YH, Jin SS, Yoon K, Min BI.
Interventions for hemiplegic shoulder pain: systematic review of randomised controlled trials. Disabil Rehabil. 2010;32:282–291.
Gamble GE, Barberan E, Laasch HU, Bowsher D, Tyrrell PJ, Jones AK.
Poststroke shoulder pain: a prospective study of the association and risk factors in 152 patients from a consecutive cohort of 205 patients presenting with stroke. Eur J Pain. 2002;6:467–474.
Lapeyre E, Kuks JB, Meijler WJ.
Spasticity: revisiting the role and the individual value of several pharmacological treatments. NeuroRehabilitation. 2010;27:193–200.
Shaw LC, Price CI, van Wijck FM, et al.
Botulinum Toxin for the Upper Limb After Stroke (BoTULS) Trial: Effect on Impairment, Activity Limitation, and Pain. Stroke. 2011;42:1371–1379.
Prevalence and predictors of pain and fatigue after stroke: a population-based study. Int J Rehabil Res. 2006;29:329–333.
Mead GE, Graham C, Dorman P, Bruins SK, Lewis SC, Dennis MS, Sandercock PA.
UK Collaborators of IST. Fatigue after stroke: baseline predictors and influence on survival. Analysis of data from UK patients recruited in the International Stroke Trial. PLoS One. 2011;6:e16988.
Winward C, Sackley C, Metha Z, Rothwell PM.
A population-based study of the prevalence of fatigue after transient ischemic attack and minor stroke. Stroke. 2009;40:757–761.
Flinn NA, Stube JE.
Post-stroke fatigue: qualitative study of three focus groups. Occup Ther Int. 2010;17:81–91.
McGeough E, Pollock A, Smith LN, et al. Interventions for post-stroke fatigue. Cochrane Database Syst Rev 2009:CD007030.
Brioschi A, Gramigna S, Werth E, et al.
Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. Eur Neurol. 2009;62:243–249.
Peuckmann V, Elsner F, Krumm N, Trottenberg P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2010:CD006788.
Nakayama H, Jorgensen HS, Pedersen PM, Raaschou HO, Olsen TS.
Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study. Stroke. 1997;28:58–62.
Thomas LH, Cross S, Barrett J, et al. Treatment of urinary incontinence after stroke in adults. Cochrane Database Syst Rev 2008:CD004462.
Rao SS, Go JT.
Update on the management of constipation in the elderly: new treatment options. Clin Interv Aging. 2010;5:163–171.
Bladin CF, Alexandrov AV, Bellavance A, et al.
Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57:1617–1622.
Berges S, Moulin T, Berger E, et al.
Seizures and epilepsy following strokes: recurrence factors. Eur Neurol. 2000;43:3–8.
Kwan J, Wood E. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke. Cochrane Database Syst Rev 2010:CD005398
Ryvlin P, Montavont A, Nighoghossian N.
Optimizing therapy of seizures in stroke patients. Neurology. 2006;67:S3–S9.
Perucca E, Tomson T.
The pharmacological treatment of epilepsy in adults. Lancet Neurol. 2011;10(5):446–456.
Tamam Y, Tamam L, Akil E, Yasan A, Tamam B.
Post-stroke sexual functioning in first stroke patients. Eur J Neurol. 2008;15:660–666.
Hope for love: practical advice for intimacy and sex after stroke. Rehabil Nurs. 2007;32:95–103.
Silver B, McCarthy S, Lu M, et al.
Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks. J Stroke Cerebrovasc Dis. 2009;18:381–383.
Hermann DM, Bassetti CL.
Sleep-related breathing and sleep-wake disturbanes in ischemic stroke. Neurology. 2009;73:1313–1322.
Chan W, Coutts SB, Hanly P.
Sleep apnea in patients with transient ischemic attack and minor stroke: opportunity for risk reduction of recurrent stroke? Stroke. 2010;41:2973–2975.
Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database Syst Rev 2008:CD003437.
Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev 2008:CD003689.
Chollet F, Tardy J, Albucher JF, et al.
Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol. 2011;10:123–130.
Rampello L, Alvano A, Chiechio S, Raffaele R, Vecchio I, Malaguarnera M.
An evaluation of efficacy and safety of reboxetine in elderly patients affected by “retarded” post-stroke depression. A random, placebo-controlled study. Arch Gerontol Geriatr. 2005;40:275–285.
Mitchell PH, Veith RC, Becker KJ, et al.
Brief psychosocial-behavioral intervention with antidepressant reduces poststroke depression significantly more than usual care with antidepressant: living well with stroke: randomized, controlled trial. Stroke. 2009;40:3073–3078.
Castillo CS, Starkstein SE, Fedoroff JP, Price TR, Robinson RG.
Generalized anxiety disorder after stroke. J Nerv Ment Dis. 1993;181:100–106.
Andersen G, Vestergaard K, Lauritzen L.
Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke. 1994;25:1099–1104.
Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsychotics for delirium. Cochrane Database Syst Rev 2007:CD005594.
House AO, Hackett ML, Anderson CS, Horrocks JA. Pharmaceutical interventions for emotionalism after stroke. Cochrane Database Syst Rev 2010:CD003690.
Dextromethorphan/Quinidine (nuedexta) for pseudobulbar affect. Med Lett Drugs Ther. 2011;53:46–47
Van den Heuvel ET, de Witte LP, Schure LM, Sanderman R.
Meyboom-de Jong B. Risk factors for burn-out in caregivers of stroke patients, and possibilities for intervention. Clin Rehabil. 2001;15:669–677.
Han B, Haley WE.
Family caregiving for patients with stroke. Review and analysis. Stroke. 1999;30:1478–1485.
Kalra L, Evans A, Perez I, et al.
Training carers of stroke patients: randomised controlled trial. BMJ. 2004;328:1099.
Puchalski C, Ferrell B, Virani R, et al.
Improving the quality of spiritual care as a dimension of palliative care: the report of the Consensus Conference. J Palliat Med. 2009;12:885–904.
Ehman JW, Ott BB, Short TH, Ciampa RC, Hansen-Flaschen J.
Do patients want physicians to inquire about their spiritual or religious beliefs if they become gravely ill? Arch Intern Med. 1999;159:1803–1806.
Quill TE, Lo B, Brock DW.
Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. JAMA. 1997;278:2099–2104.
Robinson RG, Schultz SK, Castillo C, et al.
Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry. 2000;157:351–359.
Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M.
Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke. 2000;31:1829–1832.
Li LT, Wang SH, Ge HY, Chen J, Yue SW, Yu M.
The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post- stroke depression. J Altern Complement Med. 2008;14:841–846.
Fruehwald S, Gatterbauer E, Rehak P, Baumhackl U.
Early fluoxetine treatment of post-stroke depression—a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol. 2003;250:347–351.
Murray V, von Arbin M, Bartfai A, et al.
Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression. J Clin Psychiatry. 2005;66:708–716.
Robinson RG, Jorge RE, Clarence-Smith K.
Double-blind randomized treatment of poststroke depression using nefiracetam. J Neuropsychiatry Clin Neurosci. 2008;20:178–184.
PubMed CrossRef Copyright information
© Society of General Internal Medicine 2012